RNS Number : 4855M
Halma PLC
12 June 2025
 

HALMA plc

 

FULL YEAR RESULTS 2025

 

Halma, the global group of life-saving technology companies focused on growing a safer, cleaner and healthier future for everyone, every day, today announces its full year results for the 12 months to 31 March 2025 which are available at: http://www.rns-pdf.londonstockexchange.com/rns/4855M_1-2025-6-11.pdf

 

Halma's results, together with other information about Halma, will be available on its corporate website, www.halma.com, and the results have been submitted in full unedited text to the Financial Conduct Authority's National Storage Mechanism and will shortly be available for inspection at National Storage Mechanism | FCA.

 

The webcast of the results presentation will be available on Halma's website later today: www.halma.com

 

 

Dividends

 

The Board is recommending a 7% increase in the final dividend to 14.12p per share (2024: 13.20p per share). Together with the 9.00p per share interim dividend, this will give a total dividend per share of 23.12p (2024: 21.61p).

 

The final dividend for the financial year ended 31 March 2025 is subject to approval by shareholders at the Annual General Meeting on 24 July 2025 and, if approved, will be paid on 15 August 2025 to shareholders on the register at 11 July 2025.

 

The Company offers a Dividend Reinvestment Plan ('DRIP') to enable shareholders to elect to have their cash dividends reinvested in Halma plc shares. Shareholders who wish to opt for the DRIP for the forthcoming final dividend should return a DRIP mandate form to the Company's Registrar no later than 25 July 2025.

 

Financial calendar



Ex-dividend date for 2025 final dividend

Thursday 10 July 2025

Record date for 2025 final dividend

Friday 11 July 2025

Annual General Meeting

Thursday 24 July 2025

Final date for DRIP election

Friday 25 July 2025

Payment date

Friday 15 August 2025

 

 

For further information, please contact:

Halma plc
Marc Ronchetti, Group Chief Executive
Carole Cran, Chief Financial Officer

 

Melanie Horton, Co Head of Investor Relations

Charles King, Co Head of Investor Relations

 

+44 (0)1494 721 111

 

 

+44 (0)7554 013396

+44 (0)7776 685948

MHP
Oliver Hughes/Rachel Farrington/Ollie Hoare

 

+44 (0)20 3128 8100 / +44 (0)7817 458 804

/ halma@mhpgroup.com

 

 

 

 


 

NOTE TO EDITORS

 

1.

Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. Its purpose defines the three markets it operates in:

 


·      Safety

Protecting people, assets and infrastructure in commercial, industrial and public spaces. Reducing safety risks in hazardous situations, increasing efficiency and helping to create a more sustainable future.

 

 


·      Environmental & Analysis

Monitoring and protecting the environment, and ensuring the quality and availability of lifecritical resources. Creating solutions used in materials analysis and optoelectronic applications.

 

 


·      Healthcare

 

 

Improving the care delivered by healthcare providers, and enhancing the quality of patients' lives, through contributing to the discovery and development of new cures, the diagnosis and treatment of patient conditions, and data analysis.

 

 


Halma employs over 9,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific. Halma is listed on the London Stock Exchange (LON: HLMA) and is a constituent of the FTSE 100 index.

 

Halma has been named as one of Britain's Most Admired Companies for the past six years.

 

2.

You can view or download copies of this announcement and the latest Half Year and Annual Reports from the website at www.halma.com or request free printed copies by contacting halma@halma.com.

 



 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR FZGMVLMVGKZM